Merger of Neoleukin Therapeutics, Inc. and Aquinox Pharmaceuticals, Inc. - Summary of the Assets Acquired and Liabilities Assumed (Detail) $ in Thousands	Aug. 08, 2019 USD ($)
Assets acquired:
Cash and cash equivalents	$ 3,282
Receivables, prepayments and deposits	560
Property and equipment, net	1,034
In process research and development asset	47,716
Intangible asset	659
Total assets acquired	53,251
Liabilities assumed:
Accounts payable and other liabilities	1,472
Financing lease liability	201
Total liabilities assumed	1,673
Total consideration	$ 51,578